Kazuhiko Yamada
0000-0003-4959-1780
Publication & Citation Trends
Most Cited Works
Publications
181 total
Immune checkpoint inhibitor-induced interstitial lung disease with and without CTLA-4 regimen in non-small cell lung cancer patients and PD-L1 < 1 %: A multicenter, retrospective study.
Cited by 1
Semantic Scholar
Single-arm multicenter phase II study on aggressive local consolidative therapy in combination with systemic chemotherapy for stage IV non-small cell lung carcinoma with oligometastases: CURE-OLIGO (TORG1529)
Cited by 3
Semantic Scholar
Association between skin toxicity and efficacy of necitumumab in squamous non-small-cell lung cancer: a pooled analysis of two randomized clinical trials-SQUIRE and JFCM
Cited by 2
Semantic Scholar
Low-Dose Erlotinib Treatment in Elderly or Frail Patients With <i>EGFR</i> Mutation–Positive Non–Small Cell Lung Cancer PDF
Cited by 47
OpenAlex
Lenvatinib plus anti-PD-1 antibody combination treatment activates CD8+ T cells through reduction of tumor-associated macrophage and activation of the interferon pathway PDF
Cited by 451
OpenAlex
<scp>KEYNOTE</scp>‐025: Phase 1b study of pembrolizumab in Japanese patients with previously treated programmed death ligand 1–positive advanced non–small‐cell lung cancer PDF
Cited by 48
OpenAlex
Immunomodulatory activity of lenvatinib contributes to antitumor activity in the Hepa1‐6 hepatocellular carcinoma model PDF
Cited by 332
OpenAlex
Phase III, Randomized, Placebo-Controlled, Double-Blind Trial of Motesanib (AMG-706) in Combination With Paclitaxel and Carboplatin in East Asian Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancer
Cited by 50
OpenAlex
Research Topics
Lung Cancer Treatments and Mutations
(68)
Lung Cancer Research Studies
(41)
Lung Cancer Diagnosis and Treatment
(36)
Colorectal Cancer Treatments and Studies
(27)
Cancer Immunotherapy and Biomarkers
(21)
Frequent Co-Authors
Affiliations
Kurume University
Yamagata University
Tokyo Medical and Dental University
Tufts Medical Center
Mayo Clinic